4
Changes in Ownership
COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001746251-25-000004
EVP & Chief Commercial Officer sold 17,600 shares at an average $48.17 ($847,855)
- EVP & Chief Commercial Officer acquired 17,600 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Dreyer Scott · EVP & Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +17,600 | $15.90 | $279,840 | 121,213 | D |
| 2025-12-08 | Sale : show line 2 in the form 10b5-1 | −11,125 | $47.89 | $532,771 | 110,088 | D |
| 2025-12-08 | Sale : show line 3 in the form 10b5-1 | −6,475 | $48.66 | $315,085 | 103,613 | D |
| Open-market sales · 17,600 sh · avg $48.17 · $847,855 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Purchase) | −17,600 | 0 | D |
Loading xslF345X05/form4-12102025_091236.xml…